Quarterly report · Q3
2533.TEDINET S100PEZ2
Period2022-01-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥58.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥78.6bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥56.8bn | 2021-01-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥869m | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥952m | 2021-01-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥799m | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥993m | 2021-01-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥909m | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥278m | 2021-01-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.4bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥299m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥206m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.5bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥188m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥52.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥52.3bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥49.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥22.0bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥22.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥631m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥990m | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-22.73 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.21 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.03 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.48 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.91 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | ¥11m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥2m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥381m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥1.1bn |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥151m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥273m |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | −¥880m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-09-30 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-09-30 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-09-30 | ¥9m |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-09-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-09-30 | −¥1m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥505m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥51.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥51.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥1m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥318m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥265m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥265m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥139m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.8bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.8bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2021-01-01 → 2021-09-30 | −¥20m |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥56.7bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥56.7bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥1m |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥943m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 421
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q3 | |
| Current fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-01-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2021-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Basic policy regarding control of company (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所（プライム市場） | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式 | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)同上 | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)同上 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)オエノンホールディングス株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都墨田区東駒形１丁目17番６号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |